comparemela.com
Home
Live Updates
Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones : comparemela.com
Moleculin Provides Update on Ongoing Clinical Trials and Outlines Expected Upcoming Milestones
– Announces successful completion of the Phase 1B portion of its Phase 1B/2 clinical trial Annamycin in combination with Cytarabine for the treatment of AML...
Related Keywords
United Kingdom ,
Poland ,
Houston ,
Texas ,
United States ,
Italy ,
British ,
Tacaribe Arenavirus ,
Jenene Thomas ,
Liposomal Annamycin ,
Walter Klemp ,
European Union ,
British Journal Of Cancer Research ,
National Institutes Of Health ,
Moleculin Biotech Inc ,
Drug Administration ,
Exchange Commission ,
Securities Exchange ,
Company Core Technologies ,
Linkedin ,
Twitter ,
Northwestern University ,
Facebook ,
Nasdaq ,
Moleculin Biotech ,
Chief Executive Officer ,
Generation Anthracycline ,
Recommended Phase ,
After Induction Therapy ,
British Journal ,
Serious Adverse Event ,
Report Phase ,
Transcription Modulator ,
Upcoming Milestones ,
National Institutes ,
Fast Track Status ,
Orphan Drug Designation ,
Pediatric Disease Priority Review Voucher ,
Securities Act ,
Securities Exchange Act ,
Private Securities Litigation Reform Act ,
Expected Upcoming Milestones ,
Nc ,
Biotechnology ,
Health Care Amp Hospitals ,
Pharmaceuticals ,
Medical Pharmaceuticals ,
Clinical Trials Amp Medical Discoveries ,
comparemela.com © 2020. All Rights Reserved.